Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT07479862

Not yet recruiting

A Study of SA030 Injection in Overweight or Obese Participants

Overweight | Obese
NCT07093489

Not yet recruiting

Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC) (MPX-001)

Mpox | Mpox (Monkeypox)
NCT07077356

Recruiting

Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)
NCT07055893

Not yet recruiting

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

Rabies (Healthy Volunteers)
NCT06735508

Not yet recruiting

MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

NSCLC
NCT06716151

Recruiting

A Study to Evaluate HB0034 in Healthy Chinese Adult Participants

Healthy
NCT06667206

Recruiting

Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings (BoostMe)

Measles
NCT06277128

Recruiting

A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia.

Hyperkalemia
NCT05495906

Recruiting

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV (NOVA-HIV)

Human Immunodeficiency Virus | HPV | Human Papilloma Virus
NCT05332197

Not yet recruiting

Booster Vaccine for Yellow Fever (BoVY)

Yellow Fever
NCT05231369

Recruiting

Safety and Immunogenicity of ChulaCov19 BNA159 mRNA Vaccine

Safety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Assess Which Dose is Appropriate to Use
NCT05142488

Recruiting

Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) Vaccine

COVID-19
NCT05105295

Not yet recruiting

Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV Infected

HIV Infections | COVID-19
NCT05075083

Recruiting

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD

COVID-19 | COPD | Chronic Bronchitis
NCT05075057

Recruiting

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD

COVID-19 | Copd | Chronic Bronchitis
NCT05075070

Recruiting

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV Infected

HIV Infections | COVID-19
NCT05051605

Recruiting

Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation

Liver Transplant
NCT04984512

Recruiting

The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder

Depressive Disorder, Major
NCT04932876

Recruiting

The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19

Covid19 | End Stage Kidney Disease | Vaccination | Kidney Transplantion
NCT03867643

Recruiting

Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing

Hepatitis B Vaccine Adverse Reaction
NCT05500482

Completed

Vellore Typhoid Vaccine Impact Trial (VEVACT)

Typhoid Fever
NCT05455112

Completed

Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis (CONSTAN-ARG)

Tuberculosis, Pulmonary
NCT05919901

Suspended

Multi-level School-based Intervention to Improve HPV Vaccine Uptake and Completion in South Africa

HPV
NCT05088460

Terminated

A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD) (LEAP)

Familial Partial Lipodystrophy | Metabolic Abnormalities
NCT00879762

Completed

High Dose IMVAMUNE® in Vaccinia-Naive Individuals

Smallpox
NCT05083585

Completed

A Study Evaluating the Immunogenicity of Different Clinical Trial Materials of Ad26.RSV.preF- Based Vaccine in Adults Aged 60 - 75 Years Old

Respiratory Syncytial Virus Prevention
NCT06646744

Completed

Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC) (PEDIVACOV-HCSC)

COVID-19 Vaccine Adverse Reaction
NCT05257265

Completed

A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder
NCT05858450

Completed

This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.

COVID-19 | Influenza, Human
NCT04969601

Completed

Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings (PACIFIC)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia
NCT04981717

Terminated

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

Allergic Rhinitis Due to Cat Allergy
NCT04747522

Active, not recruiting

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) (SCV-KTx-imm)

Kidney Transplant Infection | SARS-CoV Infection
NCT05913024

Completed

Immunogenicity and Safety of Enterovirus Type 71 Vaccine,Inactivated(Vero Cells) in Volunteers Aged From 6 to 71 Months

Healthy Volunteers
NCT00583752

Completed

Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 (APP21)

Recurrent Prostate Cancer
NCT00278200

Terminated

Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD

Lymphoproliferative Disorder
NCT05115019

Withdrawn

A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)

COVID-19
NCT04449276

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | COVID-19 | SARS-CoV-2 | Coronavirus
NCT04903184

Completed

Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

Covid-19
NCT04793620

Terminated

Pertussis Acellular Vaccine Adjuvanted With TQL1055

Pertussis
NCT00623831

Completed

A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Melanoma | Sarcoma | Breast Cancer | Head and Neck Cancer | Esophageal Cancer | Transitional Cell Carcinoma | Prostate Cancer | Ovarian Carcinoma | Gastrointestinal Stromal Tumor (GIST)
NCT04936997

Completed

Immune Response to the COVID-19 Vaccine

Cancer | Covid19 | Malignancy | Vaccine Response Impaired
NCT04297436

Completed

Gonococcal Vaccine Study in Key Populations in Kenya (BexKPK)

Gonorrhea
NCT03442582

Completed

Afluria Pregnancy Registry

Pregnancy | Influenza, Human | Birth Defect
NCT00001125

Completed

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

HIV Infections | Chickenpox
NCT00000837

Completed

A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children

HIV Infections
NCT00550225

Completed

Succinate Salt Version of GSK961081 for Healthy Volunteers

Pulmonary Disease, Chronic Obstructive
NCT03145324

Completed

Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations

Immunization; Infection
NCT05060861

Active, not recruiting

Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis

ChAdOx1 nCoV-19 Vaccine
NCT04385524

Withdrawn

Use of Dynavax Heplisav B in Healthcare Workers Previously Vaccinated With 3-dose Vaccine Who Failed to Demonstrate Seroprotection

Hepatitis B Virus
NCT03051386

Active, not recruiting

Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults (VEE)

Venezuelan Equine Encephalomyelitis Virus Disease

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations